High-dose buprenorphine protocol well tolerated in patients with untreated opioid use disorder; no reports of respiratory depression or sedation
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
CMS says a final decision on coverage is not likely until next spring
Major changes to prescribing instructions are rare, especially so soon after approval; change could curb the drug's use
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group
Lisdexamfetamine found to reduce symptoms of sluggish cognitive tempo in small group of adults with ADHD
Donanemab has already received a 'breakthrough therapy' designation from the FDA
No significant differences in language development seen at age 2 years for children born to mothers with epilepsy
ADHD medications may moderate the association between externalizing symptoms and risk for suicidality in children